While healthcare availability is a topic of great debate in the United States, the quality of healthcare on offer is generally not. So when Chinese citizen Guo Shushi’s stomach cancer was incurable in China and quickly killing him — Guo, with the help of a company that specializes in helping Chinese customers seek medical treatment abroad, was in Dana Farber in Boston being treated with an immunotherapy drug not currently available in China.
“When I arrived, I could feel how large the gap was,” said Mr. Guo of the difference in care.